This message was sent to ##Email##
AFMR's diverse membership positions it as one of the few organizations that bridges basic and patient-oriented research in multiple medical disciplines. AFMR members are scientists engaged in original research in clinical and laboratory medicine. As benefits of membership, all AFMR members receive:
AFMR programs offer members many opportunities to network with other clinician-scientists within their chosen field. Join today and become a part of the organization devoted to the best interests of you - the modern day medical researcher.
- A complimentary print and online subscription to the Journal of Investigative Medicine, the AFMR’s official journal. In addition, AFMR members are exempt from page charges in JIM.
- Discount on the fee to publish High Impact Case Reports in the Journal of Investigative Medicine High Impact Case Reports.
- Reduced registration fees at AFMR Regional and National Meetings, as well as for Translational Science, which is co-sponsored by the AFMR.
- Eligibility to participate on the AFMR national and regional councils and committees and the opportunity to participate on FASEB subcommittees.
- Opportunity to apply for a series of Awards - including the AFMR Outstanding Investigator Award, Junior Physician Investigator Awards, the Henry Christian Awards, and AFMR Regional Scholar Awards
- Opportunity to present work at the Regional Meetings as well as to present symposia at Experimental Biology each year - a forum for translational research. The AFMR supports participation in selected symposia and reimburses speaker expenses.
- A dedicated Members’ Only area on the AFMR website where members can update their records, access the journal, seek information on other AFMR members, and obtain important grant and career information
- Advocacy on behalf of medical investigators and researchers - the AFMR is a member of FASEB and Research!America which strengthens the AFMR’s public policy efforts.
To help further your research, we are reaching out to encourage you to publish your case reports in the Journal of Investigative Medicine High Impact Case Reports, an Open Access journal from the AFMR, and published by SAGE.
The AFMR is committed to enhancing the training and career development of its members, as well as to furthering its mission to facilitate the conduct of research to improve medical care. The publication of high quality case reports represents a critical element of investigative medical science and is an important avenue for career development. To facilitate this process, the AFMR established the Journal of Investigative Medicine High Impact Case Reports. Should you choose to become an AFMR member, you would receive a 50% discount on the fee to publish your case report in the journal.
I invite you to use the online submission site to submit or to learn more about the publication and review the instructions for authors. The Journal of Investigative Medicine High Impact Case Reports is indexed on PubMed Central. If you have any questions about submitting, please contact the National Office for assistance, at email@example.com.
Michael J. McPhaul, MD
The Association for Clinical and Translational Science (ACTS), the American Federation for Medical Research (AFMR), and the Clinical Research Forum (CRF) hosted their annual meeting, Translational Science 2016, from Wednesday, April 13 to Friday, April 15. This year’s event drew a record-breaking 940 attendees, comprised of trainees, researchers, and federal program officers. The three associations are proud to note that 597 of these attendees were at the event for the first time.
Transition to Independence: Evidence-Based Milestones and Benchmarks Myth Busting
Becoming an independent researcher is a crucial yet poorly understood step for an academic translational scientist. This session aimed to highlight the critical and timely milestones academic researchers should achieve to maximize their chances of becoming independent. Expert senior leaders used real-world data and experience to define the optimal timing, pace, and content of success in the early investigator’s career.
Chairs: Katherine Hartmann, MD, PhD, Vanderbilt University and Michael Schivo, MD, University of California, Davis
Speakers: Katherine Hartmann, MD, PhD, Associate Dean, Clinical and Translational Scientist Development, Director, Graduate Studies in Epidemiology, Professor of Obstetrics & Gynecology and Medicine, Vanderbilt University
Frederick J. Meyers, MD, MACP, Vice Dean, School of Medicine; Professor of Medicine, University of California
Serendipity in Science
This session showcased the pathways and discoveries of accomplished scientists from diverse backgrounds, including the pitfalls and strokes of luck that are keys to all great scientific careers. Serendipity strived to convey how great thinkers learn from their experiences and translate their science to the greater world. The ultimate goal of this session was to inspire beginning and established scientists alike with the speakers' wisdom gained from their careers.
Chairs: Michael Schivo, MD, MAS of the University of California, Davis and MingMing Ning, MD, MmSc of Harvard Medical School
Speakers:Jeremiah Faith, PhD, Assistant Professor of Genetics and Genomic Sciences, Medicine, and Clinical Immunology at Mount Sinai Hospital
Claire Gmachl, PhD, MSc, Director of MIRTHE, Professor of Electrical Engineering at Princeton University
Steve Small, PhD, MD, Stanley van den Noorf Professor and Chair, Professor of Neurobiology and Behavior, Professor of Cognitive Sciences, Director, Brain Imaging Center at University of California, Irving
Innovations in Academic-Industrial Collaborations: Reaching for Pioneering Funding Mechanisms
As research funding becomes increasingly competitive, investigators are seeking newer funding mechanisms. This paradigm is coupled with the need for specialized medical products (e.g., drugs, devices, etc.) to transition out of academia and into the marketplace to enhance personalized and customized medicine. In this session, expert translational scientists with track records of successful academic-industry collaborations were able to discuss the keys to optimizing this vital bridge.
Chair: Michael Schivo, MD, MAS of the University of California, Davis
Speakers: Raed Dwelk, MD, Director, Pulmonary Vascular Program, Respiratory Institute, Professor of Medicine and Pathobiology, Respiratory Institute and Learner Research Institute, the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University
Gary W. Hunter, PhD, Senior Electronics Engineer, Sensors and Electronics Branch, NASA Glenn Research Center
The 2016 Combined Annual Meeting of the Central Society for Clinical and Translational Research (CSCTR) and the Midwestern Section of the American Federation for Medical Research (MWAFMR), in Chicago, IL was a huge success! This is one of the few multispecialty meetings with a broad focus where the attendees learned research techniques used in other medical specialties and now can apply these techniques to their own research. The Combined Annual Meeting has a rich annual tradition of providing a forum for young investigators, fellows and associate/assistant professors to present their research to leaders in their fields.
The 2016 Eastern Regional Meeting of the American Federation for Medical Research took place Wednesday, April 13, 2016, at the Omni Shoreham in Washington, DC and was a great success!
• Breakfast Workshop: “Relating Mechanisms of Immune Development and Immunological Tolerance to Immune Checkpoint Inhibition in Cancer Treatments”
Chairperson: Iuliana Shapira, MD, SUNY Downstate, Brooklyn NY
Speakers: Susan Gottesman, MD, PhD, SUNY Downstate, Brooklyn NY
Christopher Roman, PhD, SUNY Downstate, Brooklyn NY
Clinical Expert: Janice Dutcher, MD, Cancer Research Foundation, Bronx NY
• 7th Annual Former AFMR President’s Address: “Crossing the Great Divide in Biomedical Research without a Horse”
Robert J. Freishtat, MD, MPH, Children's National Medical Center, Washington DC
• Research!America Advocacy Workshop: "Your Role in Shaping Science Policy through Advocacy"
Anna Briseno, Senior Communications Specialist, Research!America
• Career Development Workshop: “Building a Faculty Development Program from Scratch”
Joseph P. Merlino, MD, MPA, FACPsych, Vice President for Faculty Affairs and Professional Development, Professor of Clinical Psychiatry, SUNY Downstate, Brooklyn NY.
Research!America’s Advocacy Award honorees believe in better. A better life for you and your loved ones. A better way to find solutions to what ails us. Let’s celebrate exemplary leaders in medical, health and scientific research whose advocacy efforts have been notably effective in advancing our nation’s commitment to research. If you know an outstanding advocate whose contributions have brought us closer to cures for deadly and disabling diseases, individuals dedicated to advancing medical progress, nominate them for the 2017 Advocacy Awards!
To be considered for one of our prestigious 2017 Advocacy Awards, submit nominations here. We encourage you to nominate individuals and organizations whose noteworthy accomplishments in advocacy for medical, health and scientific research have saved lives and improved the health of our nation.
All nominations for the 2017 Advocacy Awards are due no later than May 20, 2016.
The awards will be presented on March 15, 2017 at Research!America’s Advocacy Awards Dinner in Washington, DC. The annual Research!America Advocacy Awards Program was established in 1996 by the Board of Directors to honor outstanding advocates for medical, health and scientific research. Visit our website to view the list of past award recipients and recap of the 2016 Advocacy Awards Dinner.
Twelve years ago on Friday the 13th, Lorri Carey’s life changed forever. Her neurologist asked during one of her appointments “what do you know about ALS (amyotrophic lateral sclerosis)?” Carey was a healthy and active 37-year-old with a rewarding sales career, supportive husband and two sons when her health had taken a mysterious turn. Carey knew her symptoms matched ALS, but the only thing she remembered about ALS from her research was that it was fatal. And in fact, she was told she only had two to five years to live.
Dear Research Advocate:
Last Sunday, the National Academy of Sciences presented its prestigious Public Welfare Medal to Alan Alda, actor and science communicator, who joins an esteemed group of Medal awardees, including Bill and Melinda Gates and Research!America’s Chair, former Congressman John Porter. In Alda’s acceptance remarks he described a scenario in which members of Congress passed notes to each other during testimony by scientists: “Do you get this?
Save-the-Date: Join us at the Western Regional Medical Conference (formerly known as the Western Regional Meeting), January 26-28, 2017 in Carmel California.
Save-the-Date: Join us at the Southern Regional Meeting, February 16-18, 2017 in New Orleans, Louisiana.
AFMR sponsored 2 successful symposia at Experimental Biology 2016. Next year, Experimental Biology will be held from April 22-26, 2017 in Chicago, IL. Over 14,000 physicians, scientists, and healthcare professionals are expected to attend this very prestigious multidisciplinary scientific meeting. We look forward to seeing you there!
As you review your annual giving for the upcoming year, I would like to ask you to consider a gift to the American Federation for Medical Research. Your contribution will be used to support AFMR-sponsored activities and we need your support.
With your generous donation, we can continue to offer innovative programs to help our members advance their careers at government facilities; medical centers; universities and medical schools; research institutions; and private industry in all 50 states and throughout the world. The AFMR provides young and aspiring trainees with scholarships and travel grants to attend regional meetings offering them the opportunity to present their findings to their peers and receive the guidance of senior scientists. The AFMR also recognizes trainees with national awards, such as the Henry Christian awards, named after the founder of the organization, Dr. Henry Christian. The AFMR strives to foster the development of future generations of clinical scientists and investigators through its initiatives, while encouraging public, private, and governmental investment in the development of these individuals.
Contributions are tax-deductible. Whether you choose to contribute $50, $100, $250, or another amount, I urge you to participate. I also welcome your suggestions or ideas about other potential sponsors for our programs. Most importantly, we thank you if you made a donation in 2016.
Please click here if you would like to make an online donation in 2016.
Leticia M. Ryan, MD, MPH
The way in which ketamine exerts its antidepressant effects has been perplexing. Evidence that a metabolite of the drug is responsible, and acts on a different target from ketamine, might be the key to an answer.
The New England Journal of Medicine
You are a family medicine physician practicing in a rural community 40 miles outside a major city. Your long-standing patient, Mr. Johnson, visits your clinic one afternoon, looking for a surgical referral.
Mr. Johnson is a 62-year-old man with a history of hypercholesterolemia and non–insulin-dependent diabetes mellitus.
Science Translational Medicine
The operating room may someday be run by robots, with surgeons overseeing their moves. Shademan et al. designed a “Smart Tissue Autonomous Robot,” or STAR, which consists of tools for suturing as well as fluorescent and 3D imaging, force sensing, and submillimeter positioning. With all of these components, the authors were able to use STAR for soft tissue surgery — a difficult task for a robot given tissue deformity and mobility. Surgeons tested STAR against manual surgery, laparoscopy, and robot-assisted surgery for porcine intestinal anastomosis, and found that the supervised autonomous surgery offered by the STAR system was superior.
The New England Journal of Medicine
Antiarrhythmic drugs are used commonly in out-of-hospital cardiac arrest for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia, but without proven survival benefit. In this randomized, double-blind trial, we compared parenteral amiodarone, lidocaine, and saline placebo, along with standard care, in adults who had nontraumatic out-of-hospital cardiac arrest, shock-refractory ventricular fibrillation or pulseless ventricular tachycardia after at least one shock, and vascular access.
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Rodriguez, Assistant Executive Editor, 469-420-2635 | Contribute news
Elizabeth Chouinard, AFMR Executive Director, 978-927-8330 | www.afmr.org
Elissa Klein, AFMR Associate Executive Director, 978-927-8330 | www.afmr.org
Nicole Pinkham, AFMR Administrator, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4550 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063